Gyre Therapeutics, Inc. Operating Leases, Rent Expense, Net
Gyre Therapeutics, Inc. (GYRE) reported Operating Leases, Rent Expense, Net of $400.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2019-03-08
- Gyre Therapeutics, Inc. operating leases, rent expense, net for fiscal 2018 was $400.00K, a 50.00% decline from fiscal 2017.
- Gyre Therapeutics, Inc. operating leases, rent expense, net for fiscal 2017 was $800.00K, a 14.29% increase from fiscal 2016.
- Gyre Therapeutics, Inc. operating leases, rent expense, net for fiscal 2016 was $700.00K, a 0.00% change from fiscal 2015.
- Gyre Therapeutics, Inc. operating leases, rent expense, net for fiscal 2015 was $700.00K, a 30.00% decline from fiscal 2014.
| Period end | Operating Leases, Rent Expense, Net 12 month | Operating Leases, Rent Expense, Net 12 month as first filed |
|---|---|---|
| 2018-12-31 | $400.00K 10-K · filed 2019-03-08 | |
| 2017-12-31 | $800.00K 10-K · filed 2019-03-08 | |
| 2016-12-31 | $700.00K 10-K · filed 2018-03-19 | |
| 2015-12-31 | $700.00K 10-K · filed 2017-03-08 | |
| 2014-12-31 | $1.00M 10-K · filed 2016-03-09 | $541.00K 10-K · filed 2015-03-16 |
| 2013-12-31 | $1.00M 10-K · filed 2016-03-09 | $582.00K 10-K · filed 2014-03-14 |
| 2012-12-31 | $2.82M 10-K · filed 2015-03-16 | |
| 2011-12-31 | $2.58M 10-K · filed 2014-03-14 | |
| 2010-12-31 | $2.00M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |